U.S. Markets closed

Clarification: Synta Pharma-Mover

NEW YORK (AP) -- In a story March 14, The Associated Press reported that Synta Pharmaceuticals said it planned to register a $300 million securities offering. The lead and headlines of the story should have made it clear that the filing will allow Synta to go to market with an offering if it chooses to do so, but does not guarantee the company will make an offering.